1. Clinical outcomes with drug-eluting stents, bare-metal stents, and bioresorbable scaffolds implanted in patients with AMI treated with primary PCI. Data from the Prague-18 trial. (14th October 2021) Authors: Hlinomaz, O; Sabbah, M; Knot, J; Miklik, R; Hromadka, M; Varvarovsky, I; Dusek, J; Jarkovsky, J; Tousek, F; Majtan, B; Simek, S; Branny, M; Svoboda, M; Widimsky, P; Motovska, Z Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intense antithrombotic therapy is necessary for long-term treatment in patients with symptomatic peripheral artery disease after acute myocardial infarction and primary PCI. (25th November 2020) Authors: Motovska, Z; Hlinomaz, 0; Kala, P; Knot, J; Jarkovsky, J; Hromadka, M; Varvarovsky, I; Dusek, J; Tousek, F; Simek, S; Vodzinska, A; Svoboda, M; Widimsky, P Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Relationship between symptom-onset-to-balloon time and outcomes in patients with acute myocardial infarction treated with primary percutaneous coronary intervention. (25th November 2020) Authors: Hromadka, M; Motovska, Z; Hlinomaz, O; Kala, P; Varvarovsky, I; Dusek, J; Svoboda, M; Jarkovsky, J; Tousek, F; Majtan, B; Simek, S; Branny, M; Mrozek, J; Cervinka, P; Widimsky, P Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗